公司资料
Omnicell 股价、新闻与催化剂
- 股票代码:
- OMCL
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
33.60 USD (+0.48%)
收盘价
最后更新: 2026年10月2日
1.91B USD
市值
股价为何变动
截至 2026年10月2日，OMCL 上涨 0.48%，收于 $33.60。当前新闻监测窗口内未发现新的同公司新闻。
公司概览
Medication Management Technology Company
Omnicell develops connected devices, software, and services intended to automate medication management across hospitals, health systems, and pharmacies.
Point-of-Care Automation
XT automated dispensing systems and related products control medication storage and access near the patient. The platform supports inventory visibility, security, replenishment, and integration with pharmacy and electronic health-record workflows.
Central Pharmacy Systems
Central pharmacy solutions automate medication packaging, dispensing, inventory handling, and distribution. These systems are designed to reduce manual work and improve the accuracy and traceability of hospital pharmacy operations.
IV Compounding Workflow
IVX and related technologies support sterile compounding through workflow guidance, gravimetric verification, image capture, and documentation. The products address safety and productivity in high-risk intravenous medication preparation.
Software and Technical Services
Omnicell supplements equipment sales with SaaS, analytics, implementation, maintenance, and technical services. Connected data across devices and pharmacy workflows supports its longer-term vision of autonomous medication management.
未来催化剂
近期新闻
新闻标题由机器翻译，详情为英文原文。
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。